Archives

img-01

Asia’s CDx Market Poised for Growth

According to a recent market research report by Triton Market Research, Asia’s CDX market was valued at $1.4 billion in 2022 and is likely to grow to $3.85 billion by 2030 with a CAGR of 13%. While CDX growth has already accelerated... Read More

img-01

Taiwan Food and Drug Administration (TFDA)

Contact us today for a free consultation with a Taiwan regulatory affairs consultant to discuss your specific needs. History and Overview The Taiwan Food and Drug Administration (TFDA) was established on January 1, 2010. The establishment of the TFDA followed the enactment... Read More

img-01

Telemedicine Growing in Asia

While telemedicine is now common in the West, it is also now growing in Asia. Some Asian countries recently outlined new telemedicine regulations. For example, Taiwan’s MOH recently announced draft amendments to their initial telemedicine regulation of 2018. Originally, telemedicine was to... Read More

img-01

Asia CDx Market Taking Off

While still behind the US and EU CDx markets to date, over the next 5 years, more and more CDx’s will be registered and used for precision medicine in Asia. Drug companies doing clinical trials and launching new drugs in Asia will... Read More

img-01

Taiwan: Updated regulations on UDI

On February 14, the Taiwan FDA (TFDA) promulgated new regulations for Class 2 and Class 3 medical devices. For these devices, a UDI code needs to be stamped on the outer frame of every packed medical device. For very small devices, the... Read More

img-01

Growth of Medical 3-D Printing in Asia

Contact us today for a free consultation with an Asia regulatory affairs consultant to discuss your specific needs. This article was originally published on MedTech Intelligence.  3-D printing has revolutionized product customization and digital manufacturing in various industries. In many instances, it... Read More